Remembering COVID: LigoLab’s Direct-to-Consumer Web Portal Supports School Surveillance Testing

‍

Editor’s Note: On May 11, 2023, the World Health Organization officially declared the end of the global COVID-19 Public Health Emergency. While much of the world has moved forward, healthcare professionals - especially those involved in medical laboratory operations and laboratory information systems (LIS systems) - must continue reflecting on the lessons learned and remain vigilant in preparing for future infectious disease threats.

Learn More: End of the Federal COVID-19 Public Health Emergency (PHE) Declaration

At LigoLab, our priority throughout the pandemic was to stand beside our laboratory partners. We responded rapidly to their evolving needs with advanced LIS software and direct-to-consumer lab testing solutions, helping them navigate the unprecedented challenges of the crisis. Our platform streamlined clinical lab workflow, supported patient care, and reinforced LIS lab infrastructure during one of the most demanding periods in modern healthcare.

What stood out most was the resilience and dedication of our lab partners - their steadfast response continues to inspire us. As we reflect on a pivotal moment from April 2021, we're reminded of the lasting impact of COVID-19 and the essential role modern LIS software plays in reinforcing public health preparedness.

LigoLab’s TestDirectly Platform Powers School COVID-19 Testing Nationwide with Nearly 7 Million Tests Processed

LOS ANGELES, CA –  LigoLab, leading developers of enterprise pathology lab software for medical laboratories, today announced that its direct-to-consumer lab testing platform, TestDirectly, is a full-service option that clinical laboratories can use to support COVID-19 school surveillance testing. 

The TestDirectly direct-to-consumer lab testing solution enhances a medical lab’s ability to manage patient engagement, sample collection, and medical testing while automating result reporting for patients, schools, and government agencies. 

The TestDirectly results network, composed of modern laboratories and collection centers throughout the U.S., has collected, processed, and reported nearly seven million COVID-19 tests thus far. 

“For schools to reopen safely, they will need a laboratory testing partner that can help them organize and manage their direct-to-consumer lab testing while also providing fast and accurate test results,” said LigoLab CEO Suren Avunjian. “Laboratories that can connect directly with the patient are uniquely positioned to play a leading role in any school district COVID-19 mitigation strategy.”

TestDirectly Results Enable Fast, Scalable COVID-19 Testing for Schools

As school districts prepare to welcome back students, teachers, and staff members for in-person learning, there is a critical need for COVID-19 surveillance testing. 

For clinical laboratories interested in partnering with school districts, TestDirectly offers an all-in-one pathology software solution that integrates with all laboratory information systems (LIS systems) and can be implemented within a matter of days while supporting testing event scheduling, test collection, automated patient notification, and patient result reporting. 

Learn More: Expand Laboratory Services to the Home and Improve Patient Engagement with New Direct-to-Consumer Lab Testing Business Models

With TestDirectly, school districts can organize and create testing events based on school location and patient types (such as student, teacher, staff, etc.) by uploading patient demographics into the school’s administrative portal via a CSV file or other integration. School administrators, the CDC, and other government agencies can also monitor test orders and TestDirectly results time with no delays.

After patients are uploaded into the TestDirectly system, an administrator creates testing events based on variables like patient location and type. 

Upon setting up a testing event, the system can prepare a batch testing event by generating all specimen labels at once or by automatically sending an email notification to each patient, inviting them to create their personal TestDirectly account. 

For parents with young children, the TestDirectly solution can link the parent’s email address to the child’s account. This enables the parent to log in and view their child’s test results as they are available.

TestDirectly Streamlines Diagnostic Testing with Scalable, Patient-Centered Software

TestDirectly is a powerful and intuitive SaaS system designed to help healthcare organizations become direct-to-consumer labs by expanding diagnostic testing with greater efficiency and ease. By improving accessibility, enhancing the patient experience, and accelerating result delivery, TestDirectly empowers labs and providers to scale their services without increasing overhead.

Fully HIPAA compliant and compatible with all major medical software systems - including medical LIS, lab RCM, and EMR platforms - TestDirectly eliminates many of the manual tasks associated with patient and organizational testing. This results in a streamlined clinical lab workflow that allows providers to serve more patients, deliver results faster, and operate more effectively.

Learn More: Highlighting the Versatility of the TestDirectly Direct-to-Consumer Lab Testing Portal

Learn More About TestDirectly

TestDirectly is a simple yet innovative web-based direct-to-consumer lab testing and patient engagement portal that provides turn-key point-of-care testing solutions for laboratories and collection centers. 

TestDirectly eliminates bottlenecks with automation that supports the collection and processing of specimens, the creation and delivery of reports, and the management of payment and compliance, all while also delivering a better patient experience.

Learn More: Direct-to-Consumer Lab Testing Support for Provider Insurance Discovery & Eligibility Checks‍

LigoLab: Elevating Laboratory Performance with Unified LIS and Advanced RCM Solutions

LigoLab offers a fully integrated LIS software platform that combines laboratory information system (medical LIS) and lab revenue cycle management (lab billing) functionality into one powerful pathology lab management solution.

Learn More: The Power of Integration: Unleashing the Potential of LigoLab's LIS System & Lab RCM Platform

Since 2006, LigoLab has helped clinical, reference, anatomic pathology, and molecular testing organizations streamline laboratory workflow management, ensure regulatory compliance, and increase profitability through intelligent automation and customizable processes.

By unifying medical LIS and lab RCM functionality into a single, cohesive platform, LigoLab eliminates workflow silos, reduces manual work, and improves the speed and accuracy of lab operations from start to finish - including order entry, sample tracking, diagnostic reporting, lab billing, and analytics. The platform’s scalability and flexibility make it ideal for labs of all sizes, enabling them to adapt quickly to changing regulations and business needs.

Learn More: From the Bench to the Backend - How LigoLab Turns Previous Lab Experience Into Chief Informatics Officer-Level Insight for Its Customers

With built-in business intelligence tools, labs gain real-time visibility into performance metrics, empowering better decision-making and stronger financial outcomes. 

Headquartered in Los Angeles and supported by a team that includes former lab professionals, LigoLab is committed to innovation, service, and long-term partnership, helping laboratories across the country enhance patient care and achieve sustainable growth.

Learn More: LigoLab Informatics Platform: Uniquely Designed to Deliver Maximum Value‍